These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30858725)
1. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration. Tremmel E; Hofmann S; Kuhn C; Heidegger H; Heublein S; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A Breast Cancer (Dove Med Press); 2019; 11():87-97. PubMed ID: 30858725 [TBL] [Abstract][Full Text] [Related]
2. TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC. Stavrou S; Gratz M; Tremmel E; Kuhn C; Hofmann S; Heidegger H; Peryanova M; Hermelink K; Hutter S; Toth B; Mayr D; Mahner S; Jeschke U; Vattai A Endocr Connect; 2018 Feb; 7(2):372-384. PubMed ID: 29472377 [TBL] [Abstract][Full Text] [Related]
3. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor. Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H Front Pharmacol; 2018; 9():222. PubMed ID: 29593543 [TBL] [Abstract][Full Text] [Related]
4. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection. Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G Front Pharmacol; 2017; 8():905. PubMed ID: 29311919 [TBL] [Abstract][Full Text] [Related]
5. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805 [TBL] [Abstract][Full Text] [Related]
6. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926 [No Abstract] [Full Text] [Related]
7. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer. Vattai A; Akyol E; Kuhn C; Hofmann S; Heidegger H; von Koch F; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Spitzweg C; Toth B; Mahner S; Jeschke U; Ditsch N J Cancer Res Clin Oncol; 2017 Sep; 143(9):1637-1647. PubMed ID: 28409272 [TBL] [Abstract][Full Text] [Related]
8. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1. Cöster M; Biebermann H; Schöneberg T; Stäubert C Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069 [TBL] [Abstract][Full Text] [Related]
9. Trace Amine-Associated Receptor 1 Localization at the Apical Plasma Membrane Domain of Fisher Rat Thyroid Epithelial Cells Is Confined to Cilia. Szumska J; Qatato M; Rehders M; Führer D; Biebermann H; Grandy DK; Köhrle J; Brix K Eur Thyroid J; 2015 Sep; 4(Suppl 1):30-41. PubMed ID: 26601071 [TBL] [Abstract][Full Text] [Related]
10. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine. Zhang X; Mantas I; Alvarsson A; Yoshitake T; Shariatgorji M; Pereira M; Nilsson A; Kehr J; Andrén PE; Millan MJ; Chergui K; Svenningsson P Front Pharmacol; 2018; 9():166. PubMed ID: 29545750 [TBL] [Abstract][Full Text] [Related]
11. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines. Chiellini G; Bellusci L; Sabatini M; Zucchi R Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535 [TBL] [Abstract][Full Text] [Related]
12. L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of Tremmel E; Kuhn C; Kaltofen T; Vilsmaier T; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334070 [TBL] [Abstract][Full Text] [Related]
16. Update on 3-iodothyronamine and its neurological and metabolic actions. Zucchi R; Accorroni A; Chiellini G Front Physiol; 2014; 5():402. PubMed ID: 25360120 [TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists. Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728 [TBL] [Abstract][Full Text] [Related]
18. Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders. Rutigliano G; Bräunig J; Del Grande C; Carnicelli V; Masci I; Merlino S; Kleinau G; Tessieri L; Pardossi S; Paisdzior S; Dell'Osso L; Biebermann H; Zucchi R Front Pharmacol; 2019; 10():1027. PubMed ID: 31572197 [No Abstract] [Full Text] [Related]
19. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line. Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521 [TBL] [Abstract][Full Text] [Related]